News

Redefining Local Toxicity AssessmentPart 1 - The Role of Animal-Free Non-Clinical Platforms in Drug DevelopmentIn the intricate world of drug development, the quest for precision, safety, and efficacy is unending.Traditional toxicity assessment methods using animal models, while historically significant, have shown discernible limitations in their predictability of human responses. As the biotech and pharma sectors continue to push the boundariesRead more

Top-level science through the eyes of an expert.The sixth Webinar. The sixth webinar in the Naked Immunology series is now scheduled on October 12, 2023 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Laurent Reber, Laboratory Director at the Toulouse Institute forRead more

PRESS RELEASE - Toulouse, France - June 8th, 2023 Introducing MANTIS®: A Breakthrough Analytic Pipeline for Unraveling the Complexity of Inflammatory Skin Conditions. Toulouse, France, June 8, 2023 - Genoskin is proud to announce the publication of a groundbreaking scientific article in Science Advances, introducing a new analytic pipeline called MANTIS® (Multiplexed Annotated Tissue Imaging System). The article, authored byRead more

Top-level science through the eyes of an expert.The fifth Webinar. The fifth webinar in the Naked Immunology series is now scheduled on June 30, 2023 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Cezmi Akdis, the director of the Swiss Institute ofRead more

Why testing & mitigating Injection Site Reactions is critical during drugs/vaccines development? Injection site reactions (ISR) are a common occurrence when a person receives an injection in the skin, such as a vaccine or self-administered biologics.These reactions occur due to the activation of the immune system at the injection site. When a foreign substance, such as a vaccine or medication,Read more

PRESS RELEASE - Washington D.C. - April 3, 2023 Genoskin and PharmaJet Announce Strategic Research Partnership to Advance Precision Vaccine Delivery Washington D.C., April 3, 2023 - Genoskin, a leading Franco-American TechBio company specializing in bio-stabilized immunocompetent human skin platforms, and PharmaJet, an innovative provider of Precision Delivery Systems (PDS), announce a strategic research partnership during the World Vaccine Congress.Read more